Abstract:The combination of Technetium-99m-methoxyisobutylisonitrile (Tc-99m-MIBI) single-photon emission computed tomography (SPECT) and Fluorine-18-fluorodeoxyglucose (F-18-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for myocardial perfusion/metabolic imaging is commonly used to assess myocardial viability, guide treatment strategies, and predict outcomes in patients with ischemic heart failure. [ 1 , 2 ] Hibernating myocardium (HM) is a chronic and potentially reversible myocardial dysfunction caused by ischemia. In myocardial viability imaging, perfusion-metabolism mismatch is considered a characteristic feature of HM, whereas a decrease or lack of perfusion/metabolism match indicates the presence of infarct scar tissue. [ 3 , 4 ] Research evidence suggests that the extent of functional improvement in the heart after revascularization is positively correlated with the proportion of hibernating myocardium. [ 5 ] Hence, the presence and proportion of HM and scars are critical for determining the suitability for revascularization, where more HM and fewer scars correlate with a better potential for recovery and prognosis. Therefore, an accurate assessment of HM and scars is crucial for clinical decision-making. Clinical studies [ 6 ] have shown that timely coronary revascularization to restore blood flow to the HM can improve the symptoms and prognosis of patients with ischemic heart failure. While PET/CT myocardial perfusion imaging (MPI) generally provides high-quality imaging with reduced impact from soft tissue attenuation, making it ideal for evaluating myocardial blood flow, it is not entirely free from attenuation effects. Moreover, its widespread clinical application is limited by factors such as the availability of PET/CT facilities, accessibility, and the cost of positron-emitting radiopharmaceuticals. Consequently, most clinical practice studies [ 7–9 ] have employed SPECT MPI. However, SPECT MPI is known to suffer from attenuation artifacts caused by uneven absorption of low-energy gamma photons by the breast, diaphragm, and chest wall muscles, which can lead to false positives or exacerbate perceived reductions in perfusion. [ 10 , 11 ] Our search revealed that some large-scale multicenter clinical studies, such as the STICH trial, [ 12 ] used SPECT MPI without combining it with PET/CT metabolic imaging or applying attenuation correction (AC). Furthermore, recent studies [ 8 , 13–18 ] assessing myocardial viability using SPECT MPI combined with F-18-FDG PET/CT did not analyze AC-corrected SPECT data. In patients with ischemic heart failure, the enlarged heart could further exacerbate the range and severity of attenuation artifacts, potentially leading to greater misestimation of perfusion deficits, which could, in turn, affect the calculation results of HM, Scar, and other normal myocardial areas when combined with PET/CT metabolic imaging, thereby affecting the accuracy of myocardial viability and type calculations.

To PE or Not to PE: Perfusion SPECT/CT Avoids Overdiagnosis

Comparison of test bolus and bolus tracking techniques for dual-energy CT lung perfusion scan

Diagnostic Efficacy of Lung Perfusion Scan Interpreted by PISAPED Criteria for Pulmonary Embolism: Comparison with CTPA

Enhanced Diagnostic Accuracy of Pulmonary Embolism: Integrating Low-Dose CT with V/Q SPECT

Diagnostic efficacy of perfusion scans interpreted by PISA-PED criteria for pulmonary embolism:comparison with CTPA

Radiation Optimized Dual-source Dual-energy Computed Tomography Pulmonary Angiography: Intra-individual and Inter-individual Comparison.

Detection of pulmonary embolism using dual-energy computed tomography and correlation with cardiovascular measurements: a preliminary study.

Comparative Study for Diagnostic Value Between Dual Energy CT Lung Perfusion Imaging and CT Pulmonary Angiography in Patients With Pulmonary Embolism

Comparative analysis and clinical application of imaging methods for diagnosis of pulmonary embolism

Evaluation of myocardial CT perfusion in patients presenting with acute chest pain to the emergency department: comparison with SPECT-myocardial perfusion imaging

Use of pulmonary CT angiography with low tube voltage and low-iodine-concentration contrast agent to diagnose pulmonary embolism

Diagnostic Performance Of Perfusion Computed Tomography For Differentiating Lung Cancer From Benign Lesions: A Meta-Analysis

Differentiating malignant and benign pleural effusion in patients with lung cancer: an 18F-FDG PET/CT retrospectively study

Comparison of three diagnostic strategies for suspicion of pulmonary embolism: planar ventilation-perfusion scan (V/Q), CT pulmonary angiography (CTPA) and single photon emission CT ventilation-perfusion scan (SPECT V/Q): a protocol of a randomised controlled trial

Overuse of Computed Tomography Pulmonary Angiography and Low Utilization of Clinical Prediction Rules in Suspected Pulmonary Embolism Patients at a Regional Australian Hospital

Clinical risk stratification of acute pulmonary embolism: comparing the usefulness of CTA obstruction score and pulmonary perfusion defect score with dual-energy CT

Utilization and yield of chest computed tomographic angiography associated with low positive D-dimer levels

Impact of CT attenuation correction on viable myocardium detection in combined SPECT and PET/CT: A retrospective cohort study

Assessment of myocardial perfusion with cardiac SPECT/CT for women with known coronary artery disease, prior myocardial infarction or percutaneous coronary intervention

3D-Quantitated Single Photon Emission Computed Tomography/Computed Tomography: Impact on intended Management Compared to Lung Perfusion Scan in Marginal Candidates for Pulmonary Resection

A guide for a brave future for lung ventilation/perfusion tomography: the most important pulmonary nuclear medicine technique